Skip to main content

Published locations for Controversial diabetes drug not associated with increased CV risk in patients with CAD

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Controversial diabetes drug not associated with increased CV risk in patients with CAD

User login

  • Reset your password
  • /content/controversial-diabetes-drug-not-associated-increased-cv-risk-patients-cad
  • /familypracticenews/article/76753/cad-atherosclerosis/controversial-diabetes-drug-not-associated
  • /internalmedicinenews/article/76753/cad-atherosclerosis/controversial-diabetes-drug-not-associated
  • /clinicalendocrinologynews/article/76753/cad-atherosclerosis/controversial-diabetes-drug-not
  • /ecardiologynews/article/76753/cad-atherosclerosis/controversial-diabetes-drug-not-associated
  • /cardiology/article/76753/cad-atherosclerosis/controversial-diabetes-drug-not-associated-increased-cv
  • /endocrinology/article/76753/cad-atherosclerosis/controversial-diabetes-drug-not-associated-increased
  • /internalmedicine/article/76753/cad-atherosclerosis/controversial-diabetes-drug-not-associated
  • /familymedicine/article/76753/cad-atherosclerosis/controversial-diabetes-drug-not-associated
  • /type-2-diabetes-icymi/article/76753/cad-atherosclerosis/controversial-diabetes-drug-not-associated